[Registration Closed] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
date : 10/28/2024
Tags: Cardiovascular Diseases, NCDs
![[Registration Closed] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/cvd-ncd-20241122-top.png)
In 2019, Japan enacted the “Basic Act on Countermeasures for Stroke, Heart Disease and Other CVDs to Extend Healthy Life Expectancies”, leading to comprehensive nationwide efforts to promote CVD control. Based on this law, the Japanese Government established the National Plan for the Promotion of Measures Against Cerebrovascular and Cardiovascular Diseases (hereinafter “National Plan”), while prefectures created their own Prefectural Plans for CVD control (hereinafter “Prefectural Plans”). These plans are subject to periodic review, with the National Plan revised in April 2023 and the Prefectural Plans collectively updated in April 2024, marking the beginning of their second phase. During the first phase of the National Plan, the COVID-19 pandemic presented challenges, but significant progress was made in areas like the Model Projects for Integrated Centers for Stroke and Heart Disease Support (hereinafter “Integrated Support Centers”) and the development of a CVD Database, including substantial discussions on these initiatives. However, there remain challenges in ensuring these measures adequately reflect the needs of actual service users – patients and affected individuals.
Currently, 30 prefectures have established Integrated Support Centers, serving as key hubs for regional CVD control efforts. Additionally, CVD measures are often focused on acute care, with insufficient resources dedicated to chronic care and prevention efforts, as has been noted by various stakeholders. Particular emphasis needs to be placed on promoting regional clinical pathways, cardiac rehabilitation, and education to prevent recurrence. Addressing these issues and enhancing the effectiveness of CVD control measures, while developing more beneficial systems, requires building policies that are responsive to the needs of people living with CVDs.
This symposium aims to foster collaboration among industry, government, academia, and civil society to promote CVD control based on the perspectives of people living with CVDs, advancing the implementation of effective measures in the Second Phase CVD Control Plans.
[Event Overview]
- Date & Time: Friday, November 22, 2024; 15:00-17:00 JST
- Format: Hybrid (In-Person and Online (Zoom Webinar))
- Venue: Global Business Hub Tokyo (Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo) >>Access
- Language: Japanese
- Participation Fee: Free
- Organizer: Health and Global Policy Institute (HGPI)
- Support: Japanese Circulation Association
- Capacity: Venue 80/ Online 500
[Program] (Titles omitted, no particular order) *Some parts of the program may be subject to change.
15:00-15:05 | Opening Remarks |
Hanako Jimi (Member, House of Councillors; Executive Director, Parliamentary Association for Follow-up on Stroke and Cardiovascular Disease Control Measures) | |
15:05-15:10 | Explanatory Introduction |
Ryoji Noritake (Chair, HGPI) | |
15:10-15:30 | Keynote Lecture 1 “Japan’s Progress on CVD Control in and Expectations for the Roles of People Living With or Affected by CVDs” |
Shinya Tsuruta (Director, Cancer and Disease Control Division, Public Health Bureau, Ministry of Health, Labour and Welfare (MHLW)) | |
15:30-15:50 | Keynote Lecture 2 “Necessary Steps for Promoting CVD Control Through Unified Collaboration Among Industry, Government, Academia, and Civil Society” |
Issei Komuro (Vice President, International University of Health and Welfare / Representative Director, The Japanese Cardiovascular Association) | |
16:00-17:00 | Panel Discussion “Next Steps in Achieving Citizen-Centered CVD Policies” |
Panelists: |
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)